Molecular Epidemiology, Clinical Characteristics and Risk Factors for Bloodstream Infection of Multidrug-Resistant Klebsiella pneumoniae Infections in Pediatric Patients from Tianjin, China
Mengzhu Hou,Nan Chen,Lili Dong,Yulian Fang,Rui Pan,Wei Wang,Lu Wang,Jing Ning,Hanquan Dong
DOI: https://doi.org/10.2147/IDR.S389279
2022-12-03
Infection and Drug Resistance
Abstract:Mengzhu Hou, 1, &ast Nan Chen, 2, &ast Lili Dong, 3, &ast Yulian Fang, 1 Rui Pan, 2 Wei Wang, 1 Lu Wang, 1 Jing Ning, 3 Hanquan Dong 3 1 Tianjin Pediatric Research Institute, Tianjin Children's Hospital (Children's Hospital of Tianjin University), Tianjin, People's Republic of China; 2 Department of Clinical Lab, Tianjin Children's Hospital (Children's Hospital of Tianjin University), Tianjin, People's Republic of China; 3 Department of Respiratory, Tianjin Children's Hospital (Children's Hospital of Tianjin University), Tianjin, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jing Ning; Hanquan Dong, Department of Respiratory, Tianjin Children's Hospital (Children's Hospital of Tianjin University), No. 238 Longyan Road, Beichen District, Tianjin, 300134, People's Republic of China, Tel +86 13752230008 ; +86 13820476506, Email ; Purpose: The data on pediatrics with Multidrug-Resistant (MDR) Klebsiella pneumoniae infections are scarce. This study aims to investigate the molecular epidemiology of MDR Klebsiella pneumoniae , detect the mechanism of drug resistance, and determine the clinical risk factors for carbapenem-resistant Klebsiella pneumonia (CRKP) bloodstream infections (BSIs) in a children's hospital. Methods: A total of 62 strains were collected from Tianjin Children's Hospital. Carba NP and polymerase chain reactions (PCR) were performed to detect MDR mechanisms. Multilocus sequence typing (MLST) was used for analyzing strain homology. Clinical data were collected and logistic regression was used for BSI risk factors. Results: ST11 was the principal ST among the CRKP isolates clinically, accounting for 56.45% (35/62); there were also 57.14% (20/35) ST11 CRKP strains co-carrying bla NDM-5 and bla KPC-2 , which were resistant to most of the tested antibiotics, being susceptible only to cotrimoxazole and tigecycline. The clinical data showed that 72.73% (40/55) of children with CRKP infection had serious underlying diseases; 20.00% (11/55) patients developed BSIs with the potential to cause multiple organ failure, shock and death. The logistic regression showed that the risk of BSIs caused by CRKP strain infections in children with hematological malignancies after chemotherapy was 7 times that of other children (95%Cl: 1.298– 45.415, P =0.025). Conclusion: ST11 was the prevalent clone in our hospital. The emergence of ST11 CRKP co-carrying bla NDM-5 and bla KPC-2 should be a cause for alarm as they were resistant to most of the tested antibiotics. CRKP strain infections are mainly occurring in young immunocompromised patients and the chemotherapy for hematological malignancies is an independent risk factor for BSIs. Keywords: carbapenem-resistant Klebsiella pneumonia , bla KPC-2 , bla NDM-5 , ST11, children, bloodstream infection Klebsiella pneumonia is a kind of gram-negative bacillus pathogen that causes a wide range of hospital- and community-acquired infections, mainly in immunocompromised individuals. The inappropriate use of antibiotics has attributed to the emergence of multidrug-resistant (MDR) Klebsiella pneumoniae worldwide. In the decades since, MDR Klebsiella pneumoniae has spread globally and causes a variety of infections, such as pneumonia, urinary tract infections, surgical site or wound infections, and bloodstream infections (BSIs) associated with high morbidity and mortality. 1,2 Carbapenem has the characteristics of broadest antibacterial spectrum, which is always considered as the last resort for the treatment of the infections caused by multidrug-resistant strains. 3 However, with the rapidly increasing numbers of carbapenem-resistant Enterobacterales (CRE), the Centers for Diseases Control and Prevention (CDC) classified them as an urgent threat to public health. 4,5 The World Health Organization released the Antimicrobial Resistance: Global Report on Surveillance 2014, which identified that carbapenem-resistant Klebsiella pneumonia (CRKP) infection is spreading worldwide. 6 Data relating to CRKP in the China Antimicrobial Resistance Surveillance Network (CHINET) report 2019 were analyzed: CRKP strains account for 72.4% of clinical CRE infections in China and the meropenem resistance rate in Klebsiella pneumoniae increased from 2.9% in 2005 to 26.8% in 2019. 7 Although the majority of patients infected with CRKP were adults, approximately 1–5% -Abstract Truncated-
pharmacology & pharmacy,infectious diseases